Abstract: There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein W, X, Y, Z, R1, R2 and R3 have meanings provided in the description, which compounds are useful in the treatment of cancers.
Type:
Grant
Filed:
August 5, 2016
Date of Patent:
September 7, 2021
Assignees:
The United States of America, as represented by the Secretary, Department of Health and Human Services, Elias Set Jenö Arnér
Inventors:
Elias Set Jenö Arnér, William Chester Stafford, Nathan Patrick Coussens, Diane Karen Luci, David Joseph Maloney, Anton Simeonov, Ajit Jadhav, Thomas S. Dexheimer